RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results.

PURPOSE The phase II component of RTOG 0631 assessed the feasibility and safety of spine radiosurgery (SRS) for localized spine metastases in a cooperative group setting. MATERIALS AND METHODS Patients with 1-3 spine metastasis with a Numerical Rating Pain Scale (NRPS) score ≥ 5 received 16 Gy single fraction SRS. The primary endpoint was SRS feasibility: image-guidance RT (IGRT) targeting accuracy ≤ 2mm, target volume coverage > 90% of prescription dose, maintaining spinal cord dose constraints (10 Gy to ≤ 10% of the cord volume from 5-6mm above to 5-6mm below the target or absolute spinal cord volume < 0.35cc) and other normal tissue dose constraints. A feasibility success rate < 70% was considered unacceptable for continuation of the phase III component. Based on the one-sample exact binomial test with α=0.10 (1-sided), 41 patients were required. Acute toxicity was assessed using the National Cancer Institute Common Toxicity Criteria for Adverse Events, version 3.0. RESULTS Sixty-five institutions were credentialed with spine phantom dosimetry and IGRT compliance. Forty-six patients were accrued, and 44 were eligible. There were 4 cervical, 21 thoracic and 19 lumbar sites. Median NRPS was 7 at presentation. Final pre-treatment rapid review was approved in 100%. Accuracy of image-guided SRS targeting was in compliance with the protocol in 95%. The target coverage and spinal cord dose constraint were in accordance with the protocol requirements in 100% and 97%. Overall compliance for other normal tissue constraints was per protocol in 74%. There were no cases of grade 4-5 acute treatment-related toxicity. CONCLUSION The phase II results demonstrate the feasibility and accurate use of SRS to treat spinal metastases, with rigorous quality control, in a cooperative group setting. The planned RTOG 0631 phase III component will proceed to compare pain relief and quality of life between SRS and external beam radiotherapy.

[1]  John H Suh,et al.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. , 2005, Journal of the National Cancer Institute.

[2]  P. Gerszten,et al.  Radiosurgery for the Treatment of Spinal Melanoma Metastases , 2006, Stereotactic and Functional Neurosurgery.

[3]  P. Gerszten,et al.  Single‐fraction radiosurgery for the treatment of spinal breast metastases , 2005, Cancer.

[4]  Jingeng Zhu,et al.  Image‐guided and intensity‐modulated radiosurgery for patients with spinal metastasis , 2003, Cancer.

[5]  J. Yarnold.  8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-upOn behalf of the Bone Pain Trial Working Party , 1999 .

[6]  D. Tong,et al.  The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group , 1982, Cancer.

[7]  P. Gerszten,et al.  Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. , 2005, Journal of neurosurgery. Spine.

[8]  E. Maranzano,et al.  Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: final results from a prospective trial. , 1995, International journal of radiation oncology, biology, physics.

[9]  Y. Yamada,et al.  High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. , 2008, International journal of radiation oncology, biology, physics.

[10]  R. Jain,et al.  Radiosurgical decompression of metastatic epidural compression , 2010, Cancer.

[11]  Avraham Eisbruch,et al.  Design and implementation of an anthropomorphic quality assurance phantom for intensity-modulated radiation therapy for the Radiation Therapy Oncology Group. , 2005, International journal of radiation oncology, biology, physics.

[12]  J. Rock,et al.  Pain control by image-guided radiosurgery for solitary spinal metastasis. , 2008, Journal of pain and symptom management.

[13]  S. Helweg-Larsen.  Clinical outcome in metastatic spinal cord compression. A prospective study of 153 patients , 1996, Acta neurologica Scandinavica.

[14]  J. Rock,et al.  Partial volume tolerance of the spinal cord and complications of single‐dose radiosurgery , 2007, Cancer.

[15]  Robert D Timmerman,et al.  An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. , 2008, Seminars in radiation oncology.

[16]  F. Yin,et al.  TH‐C‐BRB‐01: Credentialing Results from a Spine Anthropomorphic Phantom , 2012 .

[17]  Sonja Dieterich,et al.  CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. , 2005, Journal of neurosurgery. Spine.

[18]  M. Bilsky,et al.  Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  C. Cleeland,et al.  Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. , 2007, Journal of neurosurgery. Spine.

[20]  J. Rock,et al.  Patterns of failure after single-dose radiosurgery for spinal metastasis , 2004 .